• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由具有功能获得性突变的肌动蛋白交联蛋白表达诱导的 Hirano 小体的形成。

Formation of Hirano bodies induced by expression of an actin cross-linking protein with a gain-of-function mutation.

作者信息

Maselli Andrew, Furukawa Ruth, Thomson Susanne A M, Davis Richard C, Fechheimer Marcus

机构信息

Department of Cellular Biology, University of Georgia, Athens, Georgia 30602, USA.

出版信息

Eukaryot Cell. 2003 Aug;2(4):778-87. doi: 10.1128/EC.2.4.778-787.2003.

DOI:10.1128/EC.2.4.778-787.2003
PMID:12912897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC178389/
Abstract

Hirano bodies are paracrystalline actin filament-containing structures reported to be associated with a variety of neurodegenerative diseases. However, the biological function of Hirano bodies remains poorly understood, since nearly all prior studies of these structures were done with postmortem samples of tissue. In the present study, we generated a full-length form of a Dictyostelium 34-kDa actin cross-linking protein with point mutations in the first putative EF hand, termed 34-kDa DeltaEF1. The 34-kDa DeltaEF1 protein binds calcium normally but has activated actin binding that is unregulated by calcium. The expression of the 34-kDa DeltaEF1 protein in Dictyostelium induces the formation of Hirano bodies, as assessed by both fluorescence microscopy and transmission electron microscopy. Dictyostelium cells bearing Hirano bodies grow normally, indicating that Hirano bodies are not associated with cell death and are not deleterious to cell growth. Moreover, the expression of the 34-kDa DeltaEF1 protein rescues the phenotypes of cells lacking the 34-kDa protein and cells lacking both the 34-kDa protein and alpha-actinin. Finally, the expression of the 34-kDa DeltaEF1 protein also initiates the formation of Hirano bodies in cultured mouse fibroblasts. These results show that the failure to regulate the activity and/or affinity of an actin cross-linking protein can provide a signal for the formation of Hirano bodies. More generally, the formation of Hirano bodies is a cellular response to or a consequence of aberrant function of the actin cytoskeleton.

摘要

平野小体是一种含有平行排列肌动蛋白丝的结构,据报道与多种神经退行性疾病有关。然而,平野小体的生物学功能仍知之甚少,因为几乎所有关于这些结构的先前研究都是使用组织的尸检样本进行的。在本研究中,我们生成了一种盘基网柄菌34 kDa肌动蛋白交联蛋白的全长形式,其第一个假定的EF手结构域存在点突变,称为34 kDa DeltaEF1。34 kDa DeltaEF1蛋白能正常结合钙,但具有不受钙调节的激活肌动蛋白结合能力。通过荧光显微镜和透射电子显微镜评估,盘基网柄菌中34 kDa DeltaEF1蛋白的表达诱导了平野小体的形成。带有平野小体的盘基网柄菌细胞正常生长,这表明平野小体与细胞死亡无关,对细胞生长也无害。此外,34 kDa DeltaEF1蛋白的表达挽救了缺乏34 kDa蛋白的细胞以及同时缺乏34 kDa蛋白和α-辅肌动蛋白的细胞的表型。最后,34 kDa DeltaEF1蛋白的表达也在培养的小鼠成纤维细胞中引发了平野小体的形成。这些结果表明,未能调节肌动蛋白交联蛋白的活性和/或亲和力可提供平野小体形成的信号。更普遍地说,平野小体的形成是细胞对肌动蛋白细胞骨架异常功能的一种反应或结果。

相似文献

1
Formation of Hirano bodies induced by expression of an actin cross-linking protein with a gain-of-function mutation.由具有功能获得性突变的肌动蛋白交联蛋白表达诱导的 Hirano 小体的形成。
Eukaryot Cell. 2003 Aug;2(4):778-87. doi: 10.1128/EC.2.4.778-787.2003.
2
Formation of Hirano bodies in Dictyostelium and mammalian cells induced by expression of a modified form of an actin-crosslinking protein.由一种肌动蛋白交联蛋白的修饰形式表达诱导的盘基网柄菌和哺乳动物细胞中 Hirano 小体的形成。
J Cell Sci. 2002 May 1;115(Pt 9):1939-49. doi: 10.1242/jcs.115.9.1939.
3
Requirements for Hirano body formation.海氏小体形成的条件。
Eukaryot Cell. 2014 May;13(5):625-34. doi: 10.1128/EC.00044-14. Epub 2014 Mar 14.
4
Autophagy contributes to degradation of Hirano bodies.自噬有助于海然小体的降解。
Autophagy. 2009 Jan;5(1):44-51. doi: 10.4161/auto.5.1.7228.
5
Formation of Hirano bodies after inducible expression of a modified form of an actin-cross-linking protein.肌动蛋白交联蛋白修饰形式的诱导表达后出现 Hirano 小体。
Eukaryot Cell. 2009 Jun;8(6):852-7. doi: 10.1128/EC.00379-08. Epub 2009 Apr 10.
6
A cell culture model for investigation of Hirano bodies.用于研究 Hirano 小体的细胞培养模型。
Acta Neuropathol. 2008 Feb;115(2):205-17. doi: 10.1007/s00401-007-0275-9. Epub 2007 Nov 3.
7
Hirano body filaments contain actin and actin-associated proteins.平野小体细丝包含肌动蛋白和肌动蛋白相关蛋白。
J Neuropathol Exp Neurol. 1987 Mar;46(2):185-99. doi: 10.1097/00005072-198703000-00006.
8
Three actin cross-linking proteins, the 34 kDa actin-bundling protein, alpha-actinin and gelation factor (ABP-120), have both unique and redundant roles in the growth and development of Dictyostelium.三种肌动蛋白交联蛋白,即34 kDa肌动蛋白成束蛋白、α-辅肌动蛋白和凝胶化因子(ABP-120),在盘基网柄菌的生长和发育过程中具有独特且相互冗余的作用。
J Cell Sci. 1999 Aug;112 ( Pt 16):2737-51. doi: 10.1242/jcs.112.16.2737.
9
Calcium regulation of actin crosslinking is important for function of the actin cytoskeleton in Dictyostelium.钙对肌动蛋白交联的调节对于盘基网柄菌中肌动蛋白细胞骨架的功能很重要。
J Cell Sci. 2003 Jan 1;116(Pt 1):187-96. doi: 10.1242/jcs.00220.
10
Hirano body expression impairs spatial working memory in a novel mouse model.希兰诺小体表达缺陷导致新型小鼠空间工作记忆受损。
Acta Neuropathol Commun. 2014 Sep 2;2:131. doi: 10.1186/s40478-014-0131-9.

引用本文的文献

1
Ofloxacin as a Disruptor of Actin Aggresome "Hirano Bodies": A Potential Repurposed Drug for the Treatment of Neurodegenerative Diseases.氧氟沙星作为肌动蛋白聚集体“平野小体”的破坏剂:一种用于治疗神经退行性疾病的潜在新用途药物。
Front Aging Neurosci. 2020 Oct 6;12:591579. doi: 10.3389/fnagi.2020.591579. eCollection 2020.
2
Dictyostelium discoideum as a non-mammalian biomedical model.盘基网柄菌作为一种非哺乳动物生物医学模型。
Microb Biotechnol. 2021 Jan;14(1):111-125. doi: 10.1111/1751-7915.13692. Epub 2020 Oct 30.
3
Actin-Interacting Protein 1 Contributes to Intranuclear Rod Assembly in Dictyostelium discoideum.肌动蛋白相互作用蛋白 1 有助于盘基网柄菌的核内杆状组装。
Sci Rep. 2017 Jan 11;7:40310. doi: 10.1038/srep40310.
4
De novo actin polymerization is required for model Hirano body formation in Dictyostelium.在盘基网柄菌中,从头肌动蛋白聚合对于模型 Hirano 小体的形成是必需的。
Biol Open. 2016 Jun 15;5(6):807-18. doi: 10.1242/bio.014944.
5
Hirano body expression impairs spatial working memory in a novel mouse model.希兰诺小体表达缺陷导致新型小鼠空间工作记忆受损。
Acta Neuropathol Commun. 2014 Sep 2;2:131. doi: 10.1186/s40478-014-0131-9.
6
Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain.广野小体差异调节由 tau 和淀粉样前体蛋白细胞内域诱导的细胞死亡。
BMC Neurosci. 2014 Jun 14;15:74. doi: 10.1186/1471-2202-15-74.
7
Requirements for Hirano body formation.海氏小体形成的条件。
Eukaryot Cell. 2014 May;13(5):625-34. doi: 10.1128/EC.00044-14. Epub 2014 Mar 14.
8
Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.模型 Hirano 体可防止淀粉样前体蛋白细胞内域引发的 tau 非依赖性和 tau 依赖性细胞死亡。
PLoS One. 2012;7(9):e44996. doi: 10.1371/journal.pone.0044996. Epub 2012 Sep 18.
9
Transgenic mouse model for the formation of Hirano bodies.用于形成 Hirano 小体的转基因小鼠模型。
BMC Neurosci. 2011 Oct 6;12:97. doi: 10.1186/1471-2202-12-97.
10
Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis.AICD 和 Fe65 与 Hirano 小体的结合降低了转录激活和凋亡的起始。
Neurobiol Aging. 2011 Dec;32(12):2287-98. doi: 10.1016/j.neurobiolaging.2010.01.003. Epub 2010 Feb 4.

本文引用的文献

1
Calcium regulation of actin crosslinking is important for function of the actin cytoskeleton in Dictyostelium.钙对肌动蛋白交联的调节对于盘基网柄菌中肌动蛋白细胞骨架的功能很重要。
J Cell Sci. 2003 Jan 1;116(Pt 1):187-96. doi: 10.1242/jcs.00220.
2
Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity.神经元形态发生和结构可塑性中的肌动蛋白细胞骨架调节
Annu Rev Cell Dev Biol. 2002;18:601-35. doi: 10.1146/annurev.cellbio.18.031802.150501. Epub 2002 Apr 2.
3
Formation of Hirano bodies in Dictyostelium and mammalian cells induced by expression of a modified form of an actin-crosslinking protein.由一种肌动蛋白交联蛋白的修饰形式表达诱导的盘基网柄菌和哺乳动物细胞中 Hirano 小体的形成。
J Cell Sci. 2002 May 1;115(Pt 9):1939-49. doi: 10.1242/jcs.115.9.1939.
4
alpha-Synuclein is phosphorylated in synucleinopathy lesions.α-突触核蛋白在突触核蛋白病损伤中发生磷酸化。
Nat Cell Biol. 2002 Feb;4(2):160-4. doi: 10.1038/ncb748.
5
Protein folding and its links with human disease.蛋白质折叠及其与人类疾病的关联。
Biochem Soc Symp. 2001(68):1-26.
6
Neurodegenerative tauopathies.神经退行性tau蛋白病
Annu Rev Neurosci. 2001;24:1121-59. doi: 10.1146/annurev.neuro.24.1.1121.
7
Beyond the Qs in the polyglutamine diseases.多聚谷氨酰胺疾病中的Q之外
Genes Dev. 2001 Apr 15;15(8):925-32. doi: 10.1101/gad.888401.
8
Therapeutic opportunities in polyglutamine disease.聚谷氨酰胺疾病的治疗机遇
Nat Med. 2001 Apr;7(4):419-23. doi: 10.1038/86486.
9
Novel actin cytoskeleton: actin tubules.新型肌动蛋白细胞骨架:肌动蛋白微管。
Cell Struct Funct. 2000 Oct;25(5):291-5. doi: 10.1247/csf.25.291.
10
Aggresomes, inclusion bodies and protein aggregation.应激颗粒、包涵体与蛋白质聚集
Trends Cell Biol. 2000 Dec;10(12):524-30. doi: 10.1016/s0962-8924(00)01852-3.